Biological control yeast consortium for agricultural pathogen inhibition
A multispecies yeast consortium derived from Solanum quitoense for biocontrol of agricultural pathogens. Seven yeast strains produce antimicrobial volatiles and enzymes that inhibit pathogens like Moniliophthora roreri, offering a sustainable alternative to fungicides and antibiotics.
Overview
This research proposes the development of a multispecies yeast consortium for biological control of agricultural pathogens. Seven yeast strains isolated from Solanum quitoense have demonstrated the ability to produce secondary metabolites with antimicrobial activity against phyto- and enteropathogenic microorganisms. The consortium approach aims to leverage yeast-yeast interactions to enhance biocontrol efficacy, broaden the spectrum of target pathogens, and extend the range of environmental conditions under which the biological control is effective.
The technology addresses the growing need for sustainable alternatives to chemical fungicides and antibiotics in agriculture. By combining multiple yeast strains, the consortium may produce alternative antimicrobial compounds that single strains cannot generate independently, potentially offering more robust and versatile pathogen control.
Technical specifications
Key features:
- Seven yeast strains from different genera, all isolated from Solanum quitoense
- Production of volatile compounds that inhibit the phytopathogen Moniliophthora roreri by 59 to 99 percent
- Production of enzymes known to play a role in biological control mechanisms
- Ability to grow across a wide range of pH values and temperatures
- Potential for mixed-species biofilm formation that enhances antagonistic activity
Research approach:
- Evaluation of antagonistic activity of mixed-species biofilms against M. roreri
- Characterization of volatile and secondary metabolite production by selected yeasts
- Gene expression analysis to identify antimicrobial compound production pathways
- Metabolomic profiling of single and consortium cultures with antagonistic phenotypes
- Nutrient media optimization using Biolog plates and Plackett-Burman experimental design
Technology readiness level
The technology is currently at an early-to-mid stage of development. Previous research involving co-culture experiments with 300 microbial accessions against enteropathogenic bacteria led to the selection of the seven candidate yeast strains. Initial validation has demonstrated the biotechnological potential of these yeasts through confirmed volatile production, enzyme activity, and growth tolerance under varied environmental conditions.
Future validation will focus on characterizing the consortium's collective behavior, optimizing growth media, and identifying the specific antimicrobial compounds responsible for pathogen inhibition. Further development is needed to transition from laboratory validation to field-ready biocontrol formulations suitable for agricultural deployment.
About Agrosavia
AGROSAVIA is Colombia’s public agricultural R&D corporation near Bogotá, operating a nationwide network of research centers and experimental farms. Co-located labs, greenhouses, pilot plots and living collections—including national germplasm banks—enable rapid prototyping and access to diverse genetic resources. An outreach and innovation network links companies and producer groups to multi-site trials and farmer engagement across varied agroecological zones. Research is backed by the Government of Colombia—principally the Ministry of Agriculture and Rural Development—with competitive national and international funding, and a technology transfer function to structure collaboration and IP.
delivered to your inbox.